Effects of the non-commensal Methylococcus capsulatus Bath on mammalian immune cells

Molecular Immunology
Trine Eker ChristoffersenCharlotte Ramstad Kleiveland

Abstract

Dietary inclusions of a bacterial meal consisting mainly of the non-commensal, methanotrophic bacteria Methylococcus capsulatus Bath have been shown to ameliorate symptoms of intestinal inflammation in different animal models. In order to investigate the molecular mechanisms causing these effects, we have studied the influence of this strain on different immune cells central for the regulation of inflammatory responses. Effects were compared to those induced by the closely related strain M. capsulatus Texas and the well-described probiotic strain Escherichia coli Nissle 1917. M. capsulatus Bath induced macrophage polarization toward a pro-inflammatory phenotype, but not to the extent observed after exposure to E. coli Nissle 1917. Likewise, dose-dependent abilities to activate NF-κB transcription in U937 cells were observed, with E. coli Nissle 1917 being most potent. High levels of CD141 on human primary monocyte-derived dendritic cells (moDCs) were only detected after exposure to E. coli Nissle 1917, which collectively indicate a superior capacity to induce Th1 cell responses for this strain. On the other hand, the M. capsulatus strains were more potent in increasing the expression of the maturation markers CD80, CD83 and CD8...Continue Reading

References

May 1, 1970·Journal of General Microbiology·R WhittenburyJ F Wilkinson
Aug 1, 1995·Current Opinion in Immunology·J T Safrit, R A Koup
Mar 19, 1996·Proceedings of the National Academy of Sciences of the United States of America·L J Zhou, T F Tedder
Apr 10, 1999·The Journal of Biological Chemistry·J C ChowF Gusovsky
Sep 9, 2004·Alimentary Pharmacology & Therapeutics·A U DignassA Sturm
Jun 21, 2005·Biochemical and Biophysical Research Communications·Carsten BergesVolker Daniel
Sep 27, 2005·The Journal of Clinical Investigation·Daniel R ClayburghJerrold R Turner
Dec 22, 2006·Nature Reviews. Molecular Cell Biology·Neil D Perkins
Mar 3, 2007·Annual Review of Biochemistry·Amanda S Hakemian, Amy C Rosenzweig
Feb 2, 2008·Inflammatory Bowel Diseases·Michael Schultz
May 16, 2008·Journal of Internal Medicine·I AtreyaM F Neurath
May 27, 2008·Nature Reviews. Immunology·Janine L Coombes, Fiona Powrie
Mar 7, 2009·International Journal of Food Microbiology·Georgia ZoumpopoulouCorinne Grangette
Nov 17, 2009·Nature Immunology·William R Heath, Francis R Carbone
May 19, 2010·The Journal of Experimental Medicine·Sarah L JongbloedKristen J Radford
Nov 26, 2010·The Journal of Nutrition·Odd H RomarheimThor Landsverk
Oct 26, 2011·Nature Reviews. Immunology·Toby Lawrence, Gioacchino Natoli
Oct 26, 2011·Journal of Innate Immunity·Allan McI Mowat, Calum C Bain
Nov 13, 2012·Journal of Bacteriology·Charlotte R KleivelandPhillip B Pope
Apr 9, 2013·Frontiers in Immunology·Mario HuboHelmut Jonuleit
Oct 8, 2013·Immunobiology·Jialu YouParveen Yaqoob
Mar 29, 2014·Probiotics and Antimicrobial Proteins·Trine Eker ChristoffersenCharlotte Ramstad Kleiveland

❮ Previous
Next ❯

Citations

Feb 18, 2016·Pathogens and Disease·Chifu B HuangJeffrey L Ebersole

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

© 2021 Meta ULC. All rights reserved